Copenhagen, Denmark; March 11, 2010 - Genmab A/S (OMX: GEN) announced today its President, R&D and Chief Scientific Officer, Prof. Jan van de Winkel, Ph.D. will attend the Kempen & Co. Life Sciences Conference on March 23 in Brussels, Belgium.